POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)
| Autor: | Singh, S, Hachborn, G, Jarrett, K, Pericleous, L, Benyo, S, Maoloni, M |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S174-S175 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect